AI-Powered MRI could eliminate need for brain tumor biopsies

NCT ID NCT04313140

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether artificial intelligence can determine the grade of a brain tumor (glioma) from MRI scans alone, a so-called 'virtual biopsy.' Researchers will compare AI results with traditional tissue biopsies in 500 adults with suspected glioma. If accurate, this could make diagnosis faster and less invasive.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could provide a non-invasive way to diagnose brain tumor grade using MRI, avoiding the need for surgical biopsy.

What could go wrong

This is an early-stage diagnostic study, not a treatment. The AI may not be accurate enough to replace biopsy, and results may not apply to all patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glioma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU De Poitiers

    RECRUITING

    Poitiers, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••